BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19765733)

  • 1. Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.
    Li Y; Liu B; Dillon ST; Fukudome EY; Kheirbek T; Sailhamer EA; Velmahos G; deMoya M; Libermann TA; Alam HB
    J Surg Res; 2010 Mar; 159(1):474-81. PubMed ID: 19765733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
    Butt MU; Sailhamer EA; Li Y; Liu B; Shuja F; Velmahos GC; DeMoya M; King DR; Alam HB
    J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel application of ProteinChip technology exploring acute rejection markers of rat small bowel transplantation.
    Yamayoshi Y; Watanabe T; Tanabe M; Hoshino K; Matsumoto K; Morikawa Y; Shimadzu M; Kitajima M; Tanigawara Y
    Transplantation; 2006 Aug; 82(3):320-6. PubMed ID: 16906028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine-based detection of intestinal tight junction loss.
    Thuijls G; Derikx JP; de Haan JJ; Grootjans J; de Bruïne A; Masclee AA; Heineman E; Buurman WA
    J Clin Gastroenterol; 2010 Jan; 44(1):e14-9. PubMed ID: 19525861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell protective mechanism of valproic acid in lethal hemorrhagic shock.
    Li Y; Liu B; Sailhamer EA; Yuan Z; Shults C; Velmahos GC; deMoya M; Shuja F; Butt MU; Alam HB
    Surgery; 2008 Aug; 144(2):217-24. PubMed ID: 18656628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
    Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
    Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry.
    Gaines PJ; Powell TD; Walmsley SJ; Estredge KL; Wisnewski N; Stinchcomb DT; Withrow SJ; Lana SE
    Am J Vet Res; 2007 Apr; 68(4):405-10. PubMed ID: 17397297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
    Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
    J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of administration of valproic acid on organ function and outcome in a canine lethal hemorrhagic shock model].
    Hu S; Hou JY; Li L; Yang MX; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):471-4. PubMed ID: 21878170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock.
    Thuijls G; de Haan JJ; Derikx JP; Daissormont I; Hadfoune M; Heineman E; Buurman WA
    Shock; 2009 Feb; 31(2):164-9. PubMed ID: 18650780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of post-hemorrhagic shock mesenteric lymph.
    Fang JF; Shih LY; Yuan KC; Fang KY; Hwang TL; Hsieh SY
    Shock; 2010 Sep; 34(3):291-8. PubMed ID: 20016403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
    Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
    Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for novel biomarkers of centrally and peripehrally-acting neurotoxicants, using surface-enhanced laser desorption/ionisation-time-of-flight mass spectrometry (SELDI-TOF MS).
    Fang M; Boobis AR; Edwards RJ
    Food Chem Toxicol; 2007 Nov; 45(11):2126-37. PubMed ID: 17602814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin attenuates severe hemorrhagic shock-induced organ damage in rats.
    Lee CC; Lee RP; Subeq YM; Lee CJ; Chen TM; Hsu BG
    Resuscitation; 2009 Mar; 80(3):372-8. PubMed ID: 19150166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.